Business Description

Description
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
Name Current Vs Industry Vs History
Cash-To-Debt 0.45
Equity-to-Asset -0.14
Debt-to-Equity -5.62
Debt-to-EBITDA -0.53
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 49.7
3-Year EPS without NRI Growth Rate 44.4
3-Year FCF Growth Rate 44.4
Name Current Vs Industry Vs History
5-Day RSI 61.32
9-Day RSI 49.65
14-Day RSI 45.82
6-1 Month Momentum % 24.01
12-1 Month Momentum % -65.19

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.83
Quick Ratio 0.83
Cash Ratio 0.73

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -38.9
Shareholder Yield % -3.37

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -1.26
EV-to-EBITDA -1.26
EV-to-FCF -1.61
Earnings Yield (Greenblatt) % -79.37
FCF Yield % -79.74

Financials (Next Earnings Date:2024-05-10 Est.)

PYPD's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PYPD

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

PolyPid Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -19.67
Beta 1.67
Volatility % 93
14-Day RSI 45.82
14-Day ATR ($) 0.235989
20-Day SMA ($) 4.5569
12-1 Month Momentum % -65.19
52-Week Range ($) 3.5655 - 13.5
Shares Outstanding (Mil) 4.8

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

PolyPid Ltd Filings

Filing Date Document Date Form
No Filing Data

PolyPid Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

PolyPid Ltd Frequently Asked Questions

What is PolyPid Ltd(PYPD)'s stock price today?
The current price of PYPD is $4.56. The 52 week high of PYPD is $13.50 and 52 week low is $3.57.
When is next earnings date of PolyPid Ltd(PYPD)?
The next earnings date of PolyPid Ltd(PYPD) is 2024-05-10 Est..
Does PolyPid Ltd(PYPD) pay dividends? If so, how much?
PolyPid Ltd(PYPD) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1